Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

NCT02028663 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

Erosive Esophagitis
GERD

Interventions

DRUG: CJ-12420
DRUG: Esomeprazole

Sponsor

HK inno.N Corporation